Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes

Outcome was generally poor in this cohort of patients with RMC. Uniform loss of SMARCB1 is a key molecular feature in this tumor and mechanism of loss appears to be mostly through translocations and deletions.